Basilea Pharmaceutica is a Swiss biopharmaceutical company based in Basel that develops and commercialises medicines for serious infections and cancer. Its products include antifungal and antibiotic treatments used in hospitals, along with cancer therapies developed for specialty care. The company works with partners to make these medicines available in markets around the world, and its customers are mainly hospitals, clinicians and healthcare systems that treat patients with difficult-to-treat conditions.
On this site Basilea Pharmaceutica AG appears as a stock on the SIX Swiss Exchange (Switzerland), code BSLN, with prices in Swiss francs (CHF). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #6 of 226 on the SIX Swiss Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Switzerland yet.
TrendStrong
94/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average27.5%
From 52-week high0.0%
MomentumStrong
91/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return37.8%
6-month return35.7%
12-month, skipping last month46.6%
Stability (higher is calmer)Fair
65/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)28.6%
Worst drawdown, 1 year (smaller is calmer)-16.9%
LiquidityFair
60/100
Moderate trading activity.
See the numbers →
Avg daily value traded2.91M CHF
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Switzerland when fundamentals data for this market is added. All Switzerland stocks.
52-wk range 44.70 – 75.80Daily closes, split-adjusted
Signals
50-day average66.53
200-day average56.64
Golden/death cross (60d)Golden, 48 days ago
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)2.28
Technical summary
Daily
Strongly bullish
12 bullish · 3 neutral · 1 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
68.31
Bullish
EMA 10
68.68
Bullish
SMA 20
67.36
Bullish
EMA 20
67.80
Bullish
SMA 50
66.53
Bullish
EMA 50
65.23
Bullish
SMA 100
59.37
Bullish
EMA 100
61.63
Bullish
SMA 200
56.64
Bullish
EMA 200
57.75
Bullish
Oscillators (daily)
RSI (14)
66.13
Neutral
MACD (12, 26)
1.09
Bullish
Momentum (12)
10.23
Bullish
Stochastic %K (14)
68.42
Neutral
Williams %R (14)
-31.58
Neutral
CCI (20)
264.1
Bearish
Pivot points (classic, last session)
S3
64.40
S2
67.40
S1
69.80
Pivot
72.80
R1
75.20
R2
78.20
R3
80.60
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CHF. Educational only, not financial advice.
